Here is a biotech drug play on the coronavirus

(This story is for CNBC Pro subscribers only.)

The deadly coronavirus sent the stock market on tailspin this week as investors fled risk assets amid concerns the outbreak would disrupt the global economy. Meanwhile, investors sought to spot biotech companies that are developing vaccine or drug programs to battle the disease. Here's another name.